Opus Genetics, Inc. (IRD) insider trading

By person

16 insiders · 6 transactions

13.1×

Dr. George Magrath holds 13.1 times base salary in stock. $7.84M of shares against $598.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. George Magrath last reported holding, valued at $3.90, the price Common Stock was last bought or sold at on the open market here, on 3 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

George Magrath

Chief Executive Officer

—

$144.57K (2)

−$144.57K

2,010,636

2.42%

$7.84M

+411.7%

Benjamin R Yerxa

President

—

$117.36K (2)

−$117.36K

670,917

0.8064%

$2.62M

—

Robert E. Gagnon

Chief Financial Officer

—

$49.65K (1) scheduled

−$49.65K

542,375

0.6519%

$2.11M

—

Joseph K Schachle

Chief Operating Officer

—

$16.99K (1)

−$16.99K

286,673

0.3446%

$1.12M

+14,234%

Foundation Fighting Blindness Retinal Degeneration Fund entity

Director

—

3,236,171

3.89%

$12.62M

+26.2%

Cam Gallagher

Director

—

2,966,111

3.57%

$11.57M

+1,753%

Ashwath Jayagopal

Chief Scientific & Dev. Ofc.

—

509,233

0.6121%

$1.99M

+548.7%

Richard J Rodgers

Director

—

343,022

0.4123%

$1.34M

+43.4%

Sean Ainsworth

Director

—

321,692

0.3867%

$1.25M

+264.1%

James S J Manuso

Director

—

317,318

0.3814%

$1.24M

+140.3%

Jean Bennett

Director

—

259,019

0.3113%

$1.01M

+159.0%

Susan Benton

Director

—

243,894

0.2932%

$950.99K

+74.2%

Nirav S. Jhaveri

Chief Financial Officer

—

194,293

0.2335%

$757.59K

+29.5%

Rabourn Amy Zaremba

Head of Fin. Quality Assurance

—

188,671

0.2268%

$735.67K

+128.3%

Bernhard Hoffmann

SVP of Corp. Dev.

—

185,446

0.2229%

$723.09K

+14.0%

Adrienne L Graves

Director

—

127,514

0.1533%

$497.20K

—

Opus Genetics, Inc.

What the insiders did Net selling

By person